ATE540981T1 - Lösliche fusionsproteine enthaltend heterologe polypeptide - Google Patents

Lösliche fusionsproteine enthaltend heterologe polypeptide

Info

Publication number
ATE540981T1
ATE540981T1 AT05770112T AT05770112T ATE540981T1 AT E540981 T1 ATE540981 T1 AT E540981T1 AT 05770112 T AT05770112 T AT 05770112T AT 05770112 T AT05770112 T AT 05770112T AT E540981 T1 ATE540981 T1 AT E540981T1
Authority
AT
Austria
Prior art keywords
soluble fusion
heterologue
polypeptides
fusion proteins
soluble
Prior art date
Application number
AT05770112T
Other languages
English (en)
Inventor
Nathan Nelson
Anat Lavi-Itzkovitz
Shani Leviatan
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Application granted granted Critical
Publication of ATE540981T1 publication Critical patent/ATE540981T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05770112T 2004-08-11 2005-08-11 Lösliche fusionsproteine enthaltend heterologe polypeptide ATE540981T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60036304P 2004-08-11 2004-08-11
PCT/IL2005/000874 WO2006016370A2 (en) 2004-08-11 2005-08-11 Soluble fusion proteins comprising heterologous polypeptides

Publications (1)

Publication Number Publication Date
ATE540981T1 true ATE540981T1 (de) 2012-01-15

Family

ID=35229843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05770112T ATE540981T1 (de) 2004-08-11 2005-08-11 Lösliche fusionsproteine enthaltend heterologe polypeptide

Country Status (4)

Country Link
US (2) US7560250B2 (de)
EP (1) EP1778729B1 (de)
AT (1) ATE540981T1 (de)
WO (1) WO2006016370A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE540981T1 (de) 2004-08-11 2012-01-15 Univ Ramot Lösliche fusionsproteine enthaltend heterologe polypeptide
CA2650920C (en) 2006-05-02 2016-10-18 Proteus Biomedical, Inc. Patient customized therapeutic regimens
MY158019A (en) 2006-10-25 2016-08-30 Proteus Digital Health Inc Controlled activation ingestible identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
PT3785599T (pt) 2007-02-01 2022-10-21 Otsuka Pharma Co Ltd Sistemas de marcadores de eventos ingeríveis
CA2676280C (en) 2007-02-14 2018-05-22 Proteus Biomedical, Inc. In-body power source having high surface area electrode
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
DK2192946T3 (da) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd Kropsintern anordning med virtuel dipol signalforstærkning
CA3039236C (en) 2008-07-08 2022-05-17 Proteus Digital Health, Inc. Ingestible event marker data framework
CN104382598A (zh) * 2008-08-13 2015-03-04 普罗透斯数字保健公司 一种产生识别器的方法
SG172846A1 (en) 2009-01-06 2011-08-29 Proteus Biomedical Inc Ingestion-related biofeedback and personalized medical therapy method and system
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
CA2842952C (en) 2011-07-21 2019-01-08 Proteus Digital Health, Inc. Mobile communication device, system, and method
JP6511439B2 (ja) 2013-06-04 2019-05-15 プロテウス デジタル ヘルス， インコーポレイテッド データ収集および転帰の査定のためのシステム、装置、および方法
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
WO2016089782A1 (en) 2014-12-01 2016-06-09 Pfenex Inc. Fusion partners for peptide production
MX2019000888A (es) 2016-07-22 2019-06-03 Proteus Digital Health Inc Percepcion y deteccion electromagnetica de marcadores de evento ingeribles.
JPWO2019208724A1 (ja) * 2018-04-27 2021-05-13 国立大学法人東北大学 所定の化合物に対する膜タンパク質のスクリーニング方法及び所定の化合物の生産方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989868A (en) * 1997-09-12 1999-11-23 The Board Of Regents Of The University Of Oklahoma Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
WO2001070776A2 (en) * 2000-03-10 2001-09-27 Trustees Of Tufts College Nimr compositions and their methods of use
AU2001265009A1 (en) * 2000-05-24 2001-12-03 Curagen Corporation Human polynucleotides and polypeptides encoded thereby
ATE540981T1 (de) 2004-08-11 2012-01-15 Univ Ramot Lösliche fusionsproteine enthaltend heterologe polypeptide

Also Published As

Publication number Publication date
US20070202573A1 (en) 2007-08-30
US20090226970A1 (en) 2009-09-10
WO2006016370A2 (en) 2006-02-16
EP1778729A2 (de) 2007-05-02
EP1778729B1 (de) 2012-01-11
US7989183B2 (en) 2011-08-02
US7560250B2 (en) 2009-07-14
WO2006016370A3 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
WO2006016370A3 (en) Soluble fusion proteins comprising heterologous polypeptides
DK1844150T3 (da) Rekombinant ekspression af proteiner i en to-kædet form med disulfidbroer
CA2443365A1 (en) Methods for the recombinant production of antifusogenic peptides
TW200732472A (en) Method for the recombinant expression of a polypeptide
WO2005017149A8 (en) Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
WO1994018332A3 (en) Anthrax toxin fusion proteins and uses thereof
DE69128285D1 (de) Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung
WO2003100021A3 (en) Methods and dna constructs for high yield production of polypeptides
MX259447B (en) High level expression of proteins
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
Seeger et al. The 26S proteasome: a dynamic structure
MXPA05012336A (es) Procedimiento para producir una proteina dirigida a un plastidio en celulas vegetales.
ATE317443T1 (de) N-terminal verlängerte proteine exprimiert in hefe
CA2414978A1 (en) Preparation of a recombinant protein in a prokaryotic host cell
AU5776799A (en) Modified hcv peptide vaccines
Montemartini et al. A recombinant tyrosine aminotransferase from Trypanosoma cruzi has both tyrosine aminotransferase and alanine aminotransferase activities
WO2003100022A3 (en) Methods and dna constructs for high yield production of polypeptides
TR199802168T2 (xx) IL-16 Aktivitesine sahip işlenmiş polipeptidler, bunları üretmeye mahsus yöntemler ve bunların kullanımı.
WO2004029209A3 (en) Epitope-tagged recombinant growth arrest specific gene 6 protein
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
DE60033583D1 (de) Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
WO2024251939A3 (en) Ccr1 modulators and methods of use
WO2007147527A3 (de) Apiase-proteinkonstrukt
EP1281716A3 (de) Reinigungsverfahren auf Gründlage der Bindung von Enzymen and markierte Peptide